Development and validation of a high-quality composite real-world mortality endpoint Published June 2018 Citation Curtis, M.D., Griffith, S.D., Tucker, M, Taylor, M.D., Capra, W.B., Carrigan, G, Holzman, B, Torres, A.Z., You, P, Arnieri, B, Abernethy, A.P. . Academy Health Annual Research Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/FH_AH_2018_poster_final.pdf Authors: Sources:Academy Health Annual Research Meeting Share Posted inPublicationsMethodology More publicationsISPORApril 2026Evaluating model performance for between-country survival transportabilityAli MS, Pittell H, Horne E, Mpofu P, Zhang Q, Adamson B, et al.Publication summaryPublicationsMethodologyMultiple myelomaISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerISPORApril 2026Impact of telemedicine encounters on survival outcomes in advanced lung cancer: A time-varying cox analysis using EHR-derived dataParatane D, Adamson B, Zemplenyi APublication summaryPublicationsNon-small cell lung cancer